<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01548872</url>
  </required_header>
  <id_info>
    <org_study_id>KA/11-152</org_study_id>
    <nct_id>NCT01548872</nct_id>
  </id_info>
  <brief_title>Comparison of the Effects of Crystalloid Cardioplegia and HTK Solution for Postoperative Troponin-I and CK-MB Levels After Pediatric Cardiac Surgery</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Baskent University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Baskent University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare two different cardioplegia solutions effect on
      postoperative Troponin-I and CK-MB levels after pediatric cardiac surgery.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>December 2011</start_date>
  <completion_date type="Anticipated">December 2012</completion_date>
  <primary_completion_date type="Anticipated">December 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>myocardial protective effect of HTK solution</measure>
    <time_frame>postoperative 48 hours</time_frame>
    <description>to detect %33 difference in Troponin-I levels 4 hours postoperatively</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>hemodynamic and respiratory data</measure>
    <time_frame>postoperative 48 hours</time_frame>
    <description>arterial pressures, heart rate,blood gas analysis</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Myocardial Injury</condition>
  <arm_group>
    <arm_group_label>crystalloid cardioplegia solution</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>After aortic cross clamp 30ml/kg will be administered</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HTK solution</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>After aortic cross clamp 50ml/kg will be administered</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>HTK solution</intervention_name>
    <description>50 ml/kg bolus in 2 minutes</description>
    <arm_group_label>HTK solution</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>crystalloid cardioplegia solution</intervention_name>
    <description>30 ml/kg bolus in two minutes</description>
    <arm_group_label>crystalloid cardioplegia solution</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients scheduled for elective pediatric cardiac surgery

          -  Patients written informed consent for study participation

        Exclusion Criteria:

          -  redo surgery

          -  allergy to study drugs

          -  unstable blood pressure before cardiac surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Month</minimum_age>
    <maximum_age>6 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Selim Kuşlu</last_name>
    <phone>+90 312 212 68 68</phone>
    <phone_ext>1172</phone_ext>
    <email>selimkuslu@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Pınar Zeyneloğlu</last_name>
    <phone>+ 90 312 212 68 68</phone>
    <phone_ext>1800</phone_ext>
    <email>pinar.zeyneloglu@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Baskent University, Faculty of Medicine</name>
      <address>
        <city>Ankara</city>
        <state>Çankaya</state>
        <zip>06490</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Selim Kuşlu</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>March 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 6, 2012</study_first_submitted>
  <study_first_submitted_qc>March 6, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 8, 2012</study_first_posted>
  <last_update_submitted>March 6, 2012</last_update_submitted>
  <last_update_submitted_qc>March 6, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 8, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Baskent University</investigator_affiliation>
    <investigator_full_name>Selim Kuslu</investigator_full_name>
    <investigator_title>Anesthesiology Resident</investigator_title>
  </responsible_party>
  <keyword>HTk solution</keyword>
  <keyword>Cardioplegia</keyword>
  <keyword>myocardial protection</keyword>
  <keyword>pediatric cardiac surgery</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
    <mesh_term>Mannitol</mesh_term>
    <mesh_term>Procaine</mesh_term>
    <mesh_term>Cardioplegic Solutions</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

